The Bioentrepreneurship MBA: Options for mid-tier business schools

Abstract

Most successful Bioentrepreneurship MBA programmes are located in major metropolitan areas described as ‘biotechnology clusters’. The present study focuses on the demographics and characteristics of a private research university to determine the feasibility of offering such a programme and the appropriate format(s) for its delivery. Recommendations include that a school should not initiate a Bioentrepreneurship MBA until there is regional demand for graduates and sufficient university expertise in areas such as regulatory issues, technology transfer and bioenterprise ethics. A conservative approach would devote 1 year to curriculum and expertise development, during which the school could supplement its present MBA programme with elective courses aimed at current MBA students. A line extension of MBA with electives could also be offered to the emerging markets of (a) mid-level non-technology managers seeking biotechnology employment and (b) laboratory technicians wishing to develop business expertise. Thereafter, the school could launch an MBA programme aimed at its broader potential student market. Provision should be made for individuals not interested in obtaining an MBA to take selected courses and for those desiring a certificate. It is concluded that the issues unique to the subject area warrant its recognition as both a career and academic discipline.